cephalexin has been researched along with cefotaxime in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (50.00) | 18.7374 |
1990's | 10 (20.00) | 18.2507 |
2000's | 8 (16.00) | 29.6817 |
2010's | 6 (12.00) | 24.3611 |
2020's | 1 (2.00) | 2.80 |
Authors | Studies |
---|---|
Cimarusti, CM | 1 |
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Chairoungdua, A; Choi, BK; Endou, H; Jung, KY; Kim, DK; Kusuhara, H; Narikawa, S; Sekine, T; Shimoda, M; Sugiyama, Y; Takeda, M; Tojo, A | 1 |
Brandsch, M; Luckner, P | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
De Luca, F; Docquier, JD; Fosse, T; Giraud-Morin, C; Rossolini, GM | 1 |
Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Banerji, AK; Mahapatra, AK; Patir, R | 1 |
Inui, K; Saito, H; Yamamoto, M | 1 |
Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Uchino, J | 1 |
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 1 |
Kim, H; Kim, WJ; Ko, KY; Oh, J | 1 |
Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A | 1 |
Nies, BA | 1 |
Bhujwala, RA; Dogra, V; Gupta, BL; Rattan, A; Tahlan, A | 1 |
Balsamo, A; Broccali, G; Lapucci, A; Macchia, B; Macchia, F; Orlandini, E; Rossello, A | 1 |
Dorow, P | 1 |
Fontana, R; Pelosi, E | 1 |
Barry, AL; Jones, RN | 1 |
Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
Lin, SR; Peng, CF | 1 |
Chin, NX; Neu, HC | 1 |
Baba, S; Itoh, Y; Kawamura, S; Kinoshita, H; Kobayashi, K; Mori, Y; Onishi, S; Shimada, J; Suzuki, K; Ueda, R | 1 |
Dix, BA; Georgopapadakou, NH; Mauriz, YR | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Edelstein, MA; Finegold, SM; Gee, R; Ingram-Drake, L; MacDonald, K; Reinhardt, J; Wexler, H | 1 |
Faulkner, RD; Hiltke, MF; McAteer, JA; Silber, BM | 1 |
Blatter, MM; Bluestone, CD; Fall, P; Kenna, MA; Kurs-Lasky, M; Reisinger, KS; Stephenson, J; Wucher, FP | 1 |
Becerra, S; Godoy, J; Herrera, N; Jofre, M; Silva, J; Urdanivia, R | 1 |
Derendorf, H; Yost, RL | 1 |
Jung, K; Löffler, G; Schreiber, G | 1 |
Anderson, H; Becerra, S; Godoy, J; Herrera, N; Jofre, M; Silva, J; Urdanivia, R | 1 |
Concia, E; Marino, P; Marone, P; Verani, D | 1 |
Brogard, JM; Comte, F | 1 |
Febvre, N; Juge, F; Lecaillon, JB; Rouan, MC; Souppart, C | 1 |
Barba, D; Esposito, S; Galante, D; Scioli, C | 1 |
Bhatia, R; John, PC; Kaur, P; Singh, H | 1 |
Girbig, F; Gutjahr, U; Kowalewski, S; Kramer, W | 1 |
Ding, Q; Huang, AJ; Long, H; Sun, YL; Wang, TS | 1 |
Andrasi, M; Buglyo, P; Gaspar, A; Zekany, L | 1 |
Akashi, S; Kawai, F; Obayashi, E; Park, SY; Roper, DI; Tame, JR; Yoshida, H | 1 |
Araki, K; Fukuoka-Araki, K; Hataya, H; Higuchi, H; Horikoshi, Y; Tanaka, M | 1 |
3 review(s) available for cephalexin and cefotaxime
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
Pediatric acute dacryocystitis due to Eikenella corrodens: A case report.
Topics: Acute Disease; Aggregatibacter; Anti-Bacterial Agents; Cardiobacterium; Cefotaxime; Cephalexin; Child, Preschool; Dacryocystitis; Drug Administration Routes; Eikenella corrodens; Female; Gram-Negative Bacterial Infections; Haemophilus; Humans; Kingella; Microbial Sensitivity Tests; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
6 trial(s) available for cephalexin and cefotaxime
Article | Year |
---|---|
Risk factors in postoperative neurosurgical infection. A prospective study.
Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Central Nervous System Diseases; Cephalexin; Cerebrospinal Fluid Shunts; Cross Infection; Female; Gentamicins; Humans; Injections, Intramuscular; Male; Meningitis, Bacterial; Middle Aged; Penicillins; Premedication; Prospective Studies; Risk Factors; Surgical Wound Infection | 1992 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefixime; Cefotaxime; Cephalexin; Chronic Disease; Gram-Negative Bacteria; Haemophilus Infections; Haemophilus influenzae; Humans; Moraxella catarrhalis; Pneumococcal Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1990 |
Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1989 |
[A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
Topics: Acute Disease; Age Factors; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Humans; Infant; Otitis Media; Otitis Media, Suppurative | 1987 |
Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children.
Topics: Acute Disease; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media with Effusion; Patient Compliance | 1987 |
41 other study(ies) available for cephalexin and cefotaxime
Article | Year |
---|---|
Dependence of beta-lactamase stability on substructures within beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Isomerism; Microbial Sensitivity Tests; Oxidation-Reduction; Penicillins; Structure-Activity Relationship | 1984 |
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.
Topics: Animals; Cephaloridine; Cephalosporins; Immunohistochemistry; Kidney; Mice; Organic Anion Transporters, Sodium-Independent; Rats | 2002 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
Topics: Aeromonas; Amino Acid Sequence; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transformation, Genetic | 2010 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.
Topics: Amino Acids; Anti-Infective Agents, Urinary; Biological Transport; Cefixime; Cefotaxime; Cefotiam; Cell Line; Cell Membrane; Cells, Cultured; Cephalexin; Cephradine; Epithelium; Intestinal Mucosa; Intestines | 1992 |
Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
Topics: Biological Transport, Active; Cefixime; Cefotaxime; Ceftibuten; Cephalexin; Cephalosporins; Glucose; Humans; Hydrogen; In Vitro Techniques; Jejunum; Microvilli | 1991 |
Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
Topics: Absorption; Administration, Oral; Alkenes; Animals; Bacteria; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Chromatography; Drug Evaluation, Preclinical; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats | 1991 |
Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
Topics: Cefaclor; Cefixime; Cefotaxime; Cephalexin; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Proteus mirabilis; Streptococcus pyogenes | 1989 |
Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.
Topics: Cefazolin; Cefotaxime; Cephalexin; Drug Resistance, Microbial; Evaluation Studies as Topic; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans | 1989 |
Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
Topics: Ampicillin; Cefotaxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Penicillin G; Penicillins | 1989 |
In vitro activity and beta-lactamase stability of LY163892.
Topics: Administration, Oral; Bacteria; beta-Lactamases; Cefaclor; Cefotaxime; Cephalexin; Cephalosporins; Enzyme Stability | 1988 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
In vitro antibacterial activity of cefixime.
Topics: Amoxicillin; Ampicillin; Bacteria; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Humans; Microbial Sensitivity Tests | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Possible physiological functions of penicillin-binding proteins in Staphylococcus aureus.
Topics: Acyltransferases; Aminoacyltransferases; Bacterial Proteins; Carboxypeptidases; Carrier Proteins; Cefotaxime; Cephalexin; Escherichia coli; Hexosyltransferases; Microscopy, Electron, Scanning; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1986 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Topics: Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1987 |
Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
Topics: Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Clostridium; Digestive System; Enterobacteriaceae; Feces; Humans; Intestines; Male | 1987 |
Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
Topics: Cefaclor; Cefadroxil; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reference Values | 1987 |
[In vitro activity of 4 cephalosporins on gram-negative bacteria and Staphylococcus aureus of hospital origin].
Topics: Cefotaxime; Cephalexin; Cephalosporins; Cephalothin; Cephradine; Gram-Negative Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Staphylococcus aureus | 1985 |
Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids.
Topics: Adult; Body Fluids; Cefazolin; Cefotaxime; Cefoxitin; Ceftazidime; Cephalexin; Chromatography, High Pressure Liquid; Female; Humans; Kinetics; Spectrophotometry, Ultraviolet | 1985 |
[Interference of cephalosporins in creatinine determination].
Topics: Cefotaxime; Cephalexin; Cephalosporins; Cephalothin; Creatinine; Drug Interactions; Humans | 1985 |
[In vitro activity of cefotaxime (HR 756) compared with cephalexin, gentamycin and amikacin against Gram-negative bacteria and urinary infections].
Topics: Amikacin; Cefotaxime; Cephalexin; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Urinary Tract Infections | 1983 |
[Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Salmonella; Staphylococcus aureus | 1982 |
Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography.
Topics: Cefotaxime; Cefotiam; Cefsulodin; Cefuroxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Microchemistry; Structure-Activity Relationship | 1982 |
[Sensitivity of 5 beta-lactam antibiotics to beta-lactamase isolated from E. coli and its respective transconjugates].
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefuroxime; Cephalexin; Cephaloridine; Conjugation, Genetic; Escherichia coli; Humans | 1983 |
Transferable beta lactam resistance against cephalosporins in Salmonella typhimurium strains in India.
Topics: Cefadroxil; Cefotaxime; Cephalexin; Cephalosporin Resistance; India; Salmonella typhimurium | 1994 |
Interaction of the orally active dianionic cephalosporin cefixime with the uptake system for oligopeptides and alpha-amino-beta-lactam antibiotics in rabbit small intestine.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biological Transport; Cefixime; Cefotaxime; Cephalexin; Drug Interactions; Hot Temperature; Hydrogen-Ion Concentration; Intestine, Small; Oligopeptides; Rabbits | 1993 |
[Purity analysis of cephalosporins with capillary zone electrophoresis].
Topics: Cefazolin; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Electrophoresis, Capillary | 1999 |
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefoperazone; Cefotaxime; Cefoxitin; Cephalexin; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Potentiometry | 2007 |
Crystal structures of penicillin-binding protein 3 (PBP3) from methicillin-resistant Staphylococcus aureus in the apo and cefotaxime-bound forms.
Topics: Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Catalytic Domain; Cefotaxime; Cephalexin; Crystallography, X-Ray; Mass Spectrometry; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Mutagenesis, Site-Directed; Penicillin-Binding Proteins; Penicillins; Peptidoglycan; Sequence Alignment | 2012 |